November 3, 2026 · Industry Insights Feline GLP-1/GIP Dual Agonist HDM7006 Shows Weekly Dosing Profile in Cats HDM7006, a GLP-1/GIP dual agonist, shows a 40–52 hour half-life and low immunogenicity in healthy cats, supporting once-weekly dosing in a preclinical study. Read article →